A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon

Laura K Hummers; Carin E Dugowson; Frederick J Dechow; Robert A Wise; Jeffrey Gregory; Joel Michalek; Gayane Yenokyan; John McGready; Fredrick M Wigley

doi:10.1136/annrheumdis-2012-201536

Article info

Clinical and epidemiological research

Extended report

A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon

Authors

Laura K Hummers Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articles Google scholar articles
Carin E Dugowson Department of Medicine, Division of Rheumatology, University of Washington, Seattle, Washington, USA PubMed articles Google scholar articles
Frederick J Dechow MediQuest Therapeutics, Inc., Bothell, Washington, USA PubMed articles Google scholar articles
Robert A Wise Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articles Google scholar articles
Jeffrey Gregory Acucela Inc, Seattle Washington, USA PubMed articles Google scholar articles
Joel Michalek Department of Epidemiology and Biostatistics, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA PubMed articles Google scholar articles
Gayane Yenokyan Department of Biostatistics, Johns Hopkins School of Public Health, Baltimore, Maryland, USA PubMed articles Google scholar articles
John McGready Department of Biostatistics, Johns Hopkins School of Public Health, Baltimore, Maryland, USA PubMed articles Google scholar articles
Fredrick M Wigley Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articles Google scholar articles

Correspondence to Dr Laura Kathleen Hummers, Division of Rheumatology, Johns Hopkins University, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA; lhummers{at}jhmi.edu

View Full Text

Citation

Hummers LK, Dugowson CE, Dechow FJ, et al

A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon

Annals of the Rheumatic Diseases 2013;72:1962-1967.

Publication history

Received February 16, 2012
Revised November 1, 2012
Accepted November 18, 2012
First published December 25, 2012.

Online issue publication

November 01, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password